Latest News

Carter's, Inc. (CRI) Q2 2026 Earnings Call Transcript
Carter's, Inc. (CRI) Q2 2026 Earnings Call Transcript

Alliant Energy Corporation (LNT) Q2 2026 Earnings Call Transcript
Alliant Energy Corporation (LNT) Q2 2026 Earnings Call Transcript

Advantage Energy Ltd. (AAV:CA) Q2 2026 Earnings Call Transcript
Advantage Energy Ltd. (AAV:CA) Q2 2026 Earnings Call Transcript

Bessent highlights Trump economy, warns China has 'done a lot of kicking lately'
Scott Bessent warns China has been "kicking" the U.S. on rare earth minerals and AI IP theft, comparing the rivalry to an underwater water polo match.

Summit Therapeutics: Upgrading To Hold As Critical Approval Decision Approaches
Summit Therapeutics Inc. is upgraded from Sell to Hold as the FDA reviews its BLA for ivonescimab, with a decision expected by November 14, 2026. SMMT's pivotal HARMONI study showed statistically sign

We’re Live and We’re Walking!
Washington, DC, July 31, 2026 (GLOBE NEWSWIRE) -- UNCF's National Walk for Education is a nationwide initiative to raise the critical funds UNCF needs to fulfill our mission of support to our member H

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Planet 13 Holdings Inc. (OTCQX: PLNH)
NEW YORK, July 31, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is

The Resilient Rally: Can Markets Continue To Climb Amid Uncertainty?
Markets remain resilient despite risks. Earnings and AI are key supports.

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C. , a top complex litigation law firm, is investigating ADMA Biologics (NASDAQ: ADMA) (“ADMA Biologics” or the “Company”) for potential

Apple Q3: Discipline Doesn't Matter
Apple beat on the top and bottom lines and still sold off over 8%. I'm at a 'Hold,' and I expect it to underperform the market through year-end. Revenue hit a Q3 record of $109.4 billion, up 16.4%, wi

Ameren Corporation (AEE) Q2 2026 Earnings Call Transcript
Ameren Corporation (AEE) Q2 2026 Earnings Call Transcript

Badger Infrastructure Solutions Ltd. (BDGI:CA) Q2 2026 Earnings Call Transcript
Badger Infrastructure Solutions Ltd. (BDGI:CA) Q2 2026 Earnings Call Transcript

Magna International Inc. (MG:CA) Q2 2026 Earnings Call Transcript
Magna International Inc. (MG:CA) Q2 2026 Earnings Call Transcript

Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript

MGN INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Megan Holdings Limited Investors of Securities Class Action Lawsuit Deadline on September 8, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Megan To Contact Him Directly To Discuss Their Options If you purchased or acquired s

Coinbase Q2: The Business Improved More Than The Headlines Suggest
Coinbase posted Q2 revenue and EPS below consensus but continues to diversify away from retail crypto trading dependence. COIN achieved a 14th consecutive quarter of positive adjusted EBITDA, reduced

Why Amazon And Walmart's AI Shopping Agents Are Rigged Against ‘Made In USA'
At a moment when Google searches for American-made products are at an all-time high—except for a brief blip during the 2020 pandemic—a new study out of Columbia Law School's Center for Law and the Eco

Big Tech Earnings, Fed Decision Shape Turbulent Week
Wall Street navigated a turbulent week as investors digested the Federal Reserve's latest interest rate decision, a barrage of Big Tech earnings , and renewed geopolitical tensions.

Apple shares fall as analysts flag memory costs, supply pressures ahead
Apple Inc (NASDAQ:AAPL, XETRA:APC) shares fell nearly 10% following its latest earnings report as analysts highlighted supply constraints, rising memory costs and a more challenging margin outlook hea

iRadimed Q2 Earnings Call Highlights
iRadimed NASDAQ: IRMD reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked